3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
15
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Head and Neck Neoplasms
4
Lung Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Neuroblastoma
2
Adenocarcinoma
2
Wilms Tumor
1
Stomatitis
1
Squamous Cell Cancer of Head and Neck (SCCHN)
1
Skin Neoplasms
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Radiation Injuries
1
Prostate Cancer Metastatic
1
Prostate Adenocarcinoma
1
Pelvic Neoplasms
1
Pancreatic Adenocarcinoma
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Interventions
pembrolizumab
2
fludarabine
2
Radiosurgery
2
Paclitaxel
2
Gemcitabine
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Anthropogenic Effects
2
venetoclax
1
umbralisib
1
ublituximab
1
regorafenib
1
pazopanib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
ibrutinib
1
grapiprant
1
fludarabine phosphate
1
famitinib
1
encorafenib
1
copanlisib
1
cemiplimab
1
capivasertib
1
camrelizumab
1
brigatinib
1
binimetinib
1
axicabtagene ciloleucel
1
avelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Disease Progression
×
Radiotherapy, Image-Guided
×
Clear all
NCT06306170
2025-04-22
GYN-ART
IRCCS San Raffaele
Recruiting
1,000 enrolled